Gainers
- Moneygram International Inc MGI shares jumped 98.6% to $2.88 after the company reported a strategic partnership with Ripple. Blockchain payments firm Ripple has made an investment in MoneyGram and will also allow the group to use its XRP cryptocurrency as part of the cross-border payments process. Ripple made an initial investment of $30 million in the money transfer company, made up of common stock and a warrant to purchase common stock. Ripple purchased newly-issued common stock including the shares underlying the warrant from MoneyGram at $4.10 per share.
- Moxian, Inc. MOXC gained 35.4% to $3.1543.
- G1 Therapeutics, Inc. GTHX surged 23.8% to $24.45 after the company announced Phase 2 trial of Trilaciclib in combination with Chemotherapy showed statistically significant improvement in overall survival in women with metastatic triple negative breast cancer.
- Immuron Limited IMRN shares jumped 18.4% to $3.03.
- Lonestar Resources US Inc. LONE gained 17.5% to $2.9250.
- SunPower Corporation SPWR rose 15.7% to $9.59. Goldman Sachs upgraded SunPower from Neutral to Buy.
- Telephone and Data Systems, Inc. TDS gained 13.6% to $33.20 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight.
- United States Cellular Corporation USM rose 13% to $49.92 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight.
- Biocept, Inc. BIOC rose 10.8% to $1.13 after the company announced the commercial launch of its Target Selector NGS Breast Panel, its multi-gene liquid biopsy panel specifically developed for breast cancer.
- TimkenSteel Corporation TMST gained 9.5% to $7.72.
- Jupai Holdings Limited JP shares rose 9.4% to $2.44.
- Cesca Therapeutics Inc. KOOL gained 9.3% to $3.05 after the company's subsidiary, ThermoGenesis, received Health Canada approval for its next generation AXP II System for cord blood processing.
- ACM Research, Inc. ACMR rose 9.1% to $18.25 after highlighting strategic plan to extend access to China's capital markets.
- Intrexon Corporation XON climbed 8.9% to $8.27 after the company reported a $100 million partnership with Surterra to advance commercial scale fermentation-based cannabinoid production.
- Renewable Energy Group, Inc. REGI gained 8.5% to $15.53.
- Carvana Co. CVNA shares rose 8.3% to $68.93.
- Hovnanian Enterprises, Inc. HOV gained 8.3% to $8.05.
- Nabors Industries Ltd. NBR shares surged 8.2% to $2.1850.
- Ocular Therapeutix, Inc. OCUL gained 7.8% to $4.54.
- Snap Inc SNAP rose 6.8% to $14.47 after BTIG raised price target on stock from $15 to $20.
- Beyond Meat, Inc. BYND rose 6.6% to $181.23 after surging 12.20% on Monday.
- Sunrun Inc. RUN rose 5.3% to $17.99. Goldman Sachs upgraded Sunrun from Neutral to Buy and announced a $20 price target.
- PhaseBio Pharmaceuticals, Inc. PHAS rose 4.8% to $12.86 after the company reported preliminary results from its Phase 2a clinical trial of PB2452. Statistically significant reversal of ticagrelor was achieved within 5 minutes of initiation.
- Eiger Biopharmaceuticals Inc EIGR rose 4.6% to $10.97 after the company announced a breakthrough therapy designation granted by the FDA for avexitide for treatment of post-bariatric hypoglycemia.
- Parsons Corporation PSN shares rose 3.3% to $32.36 after reporting strong Q1 sales.
Check out these big penny stock gainers and losers
Losers
- Digital Ally, Inc. DGLY shares tumbled 42.8% to $1.6592. Axon Enterprise Inc AAXN reported the U.S. District Court for the District of Kansas has granted summary judgment in favor of the company stating that Axon's Signal technology does not infringe Digital Ally's 452 patent. The court entered judgment for Axon and dismissed the case in its entirety.
- ContraVir Pharmaceuticals, Inc. CTRV declined 38.5% to $5.97 after the company reported a 2.6 million unit offering priced at $6 per unit.
- Rockwell Medical, Inc. RMTI shares dipped 27.4% to $3.20 after the company priced its 5.83 million share offering at $3 per share.
- Biohaven Pharmaceutical Holding Company Ltd. BHVN fell 26.8% to $42.01 after the company reported proposed public $300 million offering of common shares.
- Senmiao Technology Limited AIHS dropped 26.1% to $3.39 after the company reported entry into agreements for registered direct public offering of $6.0 million of common stock and warrants.
- Vislink Technologies, Inc. VISL shares fell 18.8% to $1.745.
- Unity Biotechnology, Inc. UBX dipped 14.1% to $7.88 after the company reported topline data for Phase 1 in the first in human study of UBX0101 in patients with Osteoarthritis of the knee.
- GCP Applied Technologies Inc. GCP fell 13.2% to $22.90.
- Precipio, Inc. PRPO dropped 11.8% to $2.84 after falling 21.08% on Monday.
- Calithera Biosciences, Inc. CALA fell 10.5% to $5.19 after the company reported a common stock offering of 10 million shares.
- MOGU Inc. MOGU fell 9.1% to $3.19.
- Alder BioPharmaceuticals, Inc. ALDR shares dropped 8.4% to $11.40.
- Hemispherx Biopharma, Inc. HEB fell 7% to $4.4682 after dropping 5.51% on Monday.
- 22nd Century Group, Inc. XXII shares dropped 6.5% to $2.03.
- Ashford Hospitality Trust, Inc. AHT dipped 6.3% to $3.27.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: CryptocurrencyNewsMovers & ShakersIntraday UpdateMarketsMoversTrading IdeasGeneralEnergyLosersOil & Gas DrillingTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in